We provide personalized loan solutions to fit your needs. NMLS ID: 167907. https://bit.ly/LendNMLS
Area Sales Manager – Direct Auto
Location
Tennessee
Posted
8 days ago
Salary
Not specified
Seniority
Senior
Job Description
Job Requirements
- HS diploma or GED from accredited institution
- 3 to 5 years of outside sales experience or related field
- Ability to be effective in product / service presentation, negotiation and final closings
- Ability to prioritize and work with limited supervision, self-starter
- Ability to be effective in dealer servicing and retention
Benefits
- medical
- dental
- vision benefits
- paid time off
- paid holidays
- 401(k)
- life insurance
- long-term disability
- tuition assistance
- employee assistance program
- critical care insurance
- auto insurance
- home insurance
- pet insurance
- other ancillary insurance options
Related Guides
Related Job Pages
More Sales Jobs
Player Development Executive, Philadelphia
DraftKings Inc.Defining what it means to build and deliver the most extraordinary sports & entertainment experiences.The Crown is Yours
The Player Development Executive will be responsible for driving net revenue by proactively engaging with and developing the VIP player base through sales tactics and delivering signature VIP experiences. This role involves building strong player loyalty, executing VIP policies, compiling data to maximize performance, and resolving customer escalations.
Sr. Retail Loan Officer
Newrez LLCNewrez is a Top 5 Mortgage Lender dedicated to supporting your journey to homeownership, nationwide.
The role involves originating home purchase and refinance loans by engaging with consumers, determining their needs, and offering appropriate products. Daily tasks include taking loan applications, preparing complete loan packages with necessary documentation, and maintaining constant communication with clients through the closing process.
Senior/Advanced Lung Disease Sales Specialist (Hartford, CT) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF.
Senior/Advanced Lung Disease Sales Specialist (North Manhattan, NY) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF. This involves building professional relationships with various customer types, analyzing sales reports to develop business plans, and ensuring maximal product messaging and education.
